Publications by authors named "David Routledge"

Claim this Profile
I
Integrating International Consensus Guidelines for Anticancer Drug Dosing in Kidney Dysfunction (ADDIKD) into everyday practice.
Geeta Sandhu, Josephine Adattini, Evangeline Armstrong Gordon, Niamh O'Neill, Corrinne Bagnis, David J Routledge

EClinicalMedicine· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aligning kidney function assessment in patients with cancer to global practices in internal medicine.
Geeta Sandhu, Josephine Adattini, Evangeline Armstrong Gordon, Niamh O'Neill, Corrine Bagnis, David J M Routledge

EClinicalMedicine· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Informing Implementation Strategies for Pharmacogenomics in Cancer: Development of Survey Tools for Healthcare Professionals and Consumers.
Marliese Alexander, Chiao Xin Lim, Senthil Lingaratnam, Sarah Glewis, Joanne Wickens, David Routledge

Clin Transl Sci· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The prognostic impact of t(11;14) in multiple myeloma: A real-world analysis from the Australian Lymphoma Leukaemia Group (ALLG) and the Australian Myeloma and Related Diseases Registry (MRDR).
Kenneth Jc Lim, Cameron Wellard, Dipti Talaulikar, Joanne Lc Tan, Joanna Loh, David Routledge

EJHaem· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
VEXAS syndrome: A dermatological perspective.
Jacqueline K Nguyen, David Routledge, Carrie van Der Weyden, Piers Blombery, Christopher M Angel

Australas J Dermatol· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Infective hyperammonaemic encephalopathy after allogeneic stem cell transplant.
Michael J Shipton, Paul M Kinsella, Thomas Davis, Francesca Azzato, George Taiaroa, David Routledge

Bone Marrow Transplant· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The evolving status of immunotherapies in multiple myeloma: the future role of bispecific antibodies.
Dawn Swan, David Routledge, Simon Harrison

Br J Haematol· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The development of a home-based therapeutic platform for multiple myeloma.
Hayley Beer, David Routledge, Trish Joyce, Emma-Jane Furphy, Nella Combe

Expert Rev Hematol· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Consensus guidelines for improving patients' understanding of invasive fungal disease and related risk prevention in the haematology/oncology setting, 2021.
Shevon S Fernando, Emma K Paige, Claire Dendle, Robert Weinkove, David C M Kong, David J Routledge

Intern Med J· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Belantamab mafodotin in combination with novel agents in relapsed/refractory multiple myeloma: DREAMM-5 study design.
Ajay K Nooka, Katja Weisel, Niels Wcj van de Donk, David Routledge, Paula Rodriguez Otero

Future Oncol· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes Following Extracorporeal Photopheresis for Chronic Lung Allograft Dysfunction Following Lung Transplantation: A Single-Center Experience.
Jaideep Vazirani, David Routledge, Greg I Snell, Doug Watson, Miranda Paraskeva

Transplant Proc· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Autologous stem cell transplantation in elderly multiple myeloma patients aged ≥65 years: a two-centre Australian experience.
Jeremy Er, David Routledge, Jennifer Hempton, Colin Wood, Trish Joyce

Intern Med J· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Time from autologous to allogeneic hematopoietic stem cell transplantation impacts post-transplant outcomes in multiple myeloma.
Salvatore Fiorenza, David Routledge, Jenny Collins, Michael Shipton, Simon Harrison

Bone Marrow Transplant· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Successful management of acute myeloid leukaemia in a twin pregnancy - a case report.
David J M Routledge, Clare Tower, Elizabeth Davies, Martin Scott, Marie Waller

Br J Haematol· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recent advances in therapy of chronic lymphocytic leukaemia.
David J M Routledge, Adrian J C Bloor

Br J Haematol· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis